| Serial Number | 79414175 |
| Word Mark | GRAFALON |
| Filing Date | Tuesday, December 10, 2024 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, January 20, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, January 20, 2026 |
| Goods and Services | Medical services; medical, pharmaceutical and biopharmaceutical services in the nature of medical and pharmaceutical consultation and medical advice and information in the field of oncology, hematology, stem cell transplantation, organ transplantation and immunological therapy. |
| Goods and Services | Scientific services and research for medical purposes, namely medical and scientific research in the field of cell biology and antibodies and immunology; scientific and technological services, namely scientific research, analysis, testing in the field of biotechnology, biopharmaceutics and medical science; biotechnological and biopharmaceutical analyses, namely blood analysis services for scientific research purpose, cell analysis services for scientific research purpose, DNA analysis services for scientific research purpose, human leukocyte antigen (HLA) analysis services for scientific research purpose , antibodies analysis services for scientific research purpose, antigen analysis services for scientific research purposes, Technical research in the field of pharmaceutical studies; medical research laboratory services. |
| Goods and Services | Pharmaceutical compositions and preparations, namely, pharmaceutical preparations for the treatment of anti-neutrophil cytoplasmic antibody associated vasculitis, aplastic anemia, autoimmune diseases, diabetes, and for the prevention and treatment of graft-versus-host disease, hemophagocytic lymphohistiocytosis, lupus nephritis, multiple sclerosis, myelodysplastic syndrome, myelofibrosis, systemic lupus erythematosus, as well as for use in organ and tissue transplantation; biopharmaceutical compositions and preparations, in particular those for use in the treatment of immunological conditions, tissue, stem cell and organ transplants, tumors and immune system conditions; medicinal preparations for the treatment of infectious diseases and for use in oncology and hematology; medicinal preparations for use in stem cell transplant procedures; medicinal preparations for use in organ transplant procedures. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, January 2, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, January 2, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, January 2, 2025 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Neovii Biotech GmbH |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | DE |
| Party Name | Neovii Biotech GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | DE |
| Event Date | Event Description |
| Thursday, January 2, 2025 | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB |
| Saturday, January 11, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, January 11, 2025 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, May 28, 2025 | ASSIGNED TO EXAMINER |
| Saturday, May 31, 2025 | NON-FINAL ACTION WRITTEN |
| Sunday, June 1, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, July 24, 2025 | REFUSAL PROCESSED BY MPU |
| Thursday, July 24, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, August 8, 2025 | REFUSAL PROCESSED BY IB |
| Monday, November 24, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, November 24, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, November 24, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, December 18, 2025 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, December 18, 2025 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, December 18, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, December 18, 2025 | EXAMINER'S AMENDMENT ENTERED |
| Friday, December 19, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, January 14, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, January 20, 2026 | PUBLISHED FOR OPPOSITION |
| Tuesday, January 20, 2026 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |